The Approval Process in Action
Source: The Life Sciences Report and Visual Capitalist (5/1/13)
What catalysts in the drug development process move biotech company stocks? The savvy investor must know what steps in the U.S. Food and Drug Administration's approval process can propel a stock up or down. From drug discovery to the much-anticipated PDUFA date, The Life Sciences Report and the Visual Capitalist have collaborated on an infographic that describes both the process and related catalysts.
Related Articles
Gold at Year-End and a Lesson in Shorting
Source: Ron Struthers for Streetwise Reports (10/17/2017)
Cannabis Company Forms Partnership to Develop Pharmaceuticals
Source: Streetwise Reports (10/06/2017)
Telemedicine Platform Is Quickly Gaining Traction in Fast Growing Market
Source: Streetwise Reports (10/05/2017)
Biotech with Transformative RNAi Delivery System Set for Multiple Catalysts by Year-End
Source: Streetwise Reports (10/04/2017)
Small Biotech Enters Patent Deal with British Company Targeting Schizophrenia
Source: Streetwise Reports (10/04/2017)
Japan Is Fertile Ground for Biotech Deals
Source: Streetwise Reports (10/04/2017)
Source: Streetwise Reports (09/27/2017)
Possible 'Best-in-Class' Alzheimer's Drug Candidate Offers 'Disruptive' Potential
Source: Streetwise Reports (09/20/2017)
Gout, Kidney Stones, Liver Disease & Cannabinoids
Source: Danny Deadlock for Streetwise Reports (09/15/2017)
Biopharma Gets Green Light for Hypertension Study
Source: Streetwise Reports (09/13/2017)
